OWD
BIO icon

Osborn Williams & Donohoe’s Bio-Rad Laboratories Class A BIO Stock Holding History

Osborn Williams & Donohoe’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-320
Closed -$98K – 358
2019
Q1 		$98K Buy
+320
New +$86.4K 0.01% 414

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Osborn Williams & Donohoe's BIO Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2019, closing a stake of 320 shares — an estimated $98K sold.

Osborn Williams & Donohoe first reported a position in BIO in Q1 2019 and held it in 1 quarter. The position peaked at $98K in Q1 2019. 330 funds tracked by Wall St. Rank hold BIO as of Q2 2019.

  • Osborn Williams & Donohoe reported no remaining Bio-Rad Laboratories Class A position as of Q2 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 320 Bio-Rad Laboratories Class A shares in Q2 2019, an estimated $98K.
  • Osborn Williams & Donohoe first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 1 quarter.
  • Osborn Williams & Donohoe's Bio-Rad Laboratories Class A position peaked at $98K in Q1 2019.
  • 330 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.